Pharmaceutical & Cosmetic Review April 2020

Page 14

COMPANY FOCUS

Strong, profitable and confident about the future Symrise continued its profitable growth course in 2019, achieving all its targets for the year. This was made possible by an 8.0% increase in group sales, amounting to 5.7% growth in organic sales. A significant portion of this growth was seen in the company’s fragrances division, which experienced strong demand for fine fragrance products.

T

aking portfolio and exchange

the year and rolled out new technologies

rate effects into account, Symrise’s

around the world. These targeted growth

in the 2019 fiscal year and significantly

sales increased by 8.0% to €3.

initiatives, combined with our disciplined

exceeded the previous year’s level, with

408 million (2018: €3. 154 million).

cost management programme, are

an ebitda(N) margin of 20.8%. As a result,

As a result, Symrise was again one of

clearly reflected in our operational

the group was once again one of the most

the fastest-growing companies in the

development in recent quarters,” said Dr

profitable companies in the industry.

fragrances and flavours industry. This strong

Heinz-Jürgen Bertram, CEO of Symrise.

Normalised net income increased by

performance was carried by good demand

“Along with our customers, the capital

10.2% year-on-year to €303.5 million (2018:

across all segments and regions. Earnings

market has also responded favourably

€275.3 million). This led to an increase in

before interest, taxes, depreciation and

to our performance. The share price

normalised earnings per share to €2.25

amortisation (ebitda) as well as normalised

increased by 42% in 2019. This year, we

(2018: €2.12). Against the backdrop of the

for one-time effects resulting from the

want our shareholders to participate

positive growth in earnings, the executive

acquisition of ADF/IDF, ebitda(N) increased

again in our success. At Symrise’s AGM,

board and supervisory board of Symrise will

by €76.7 million to €707.2 million.

the executive board and supervisory

propose a dividend of €0.95 per share (2018:

board will propose a dividend increase to

€0.90) at its AGM. Originally planned for 6

€0.95 per share.”

May, the AGM has since been postponed

“Once again, Symrise posted strong growth in 2019. With the acquisition of ADF/IDF, we have continued to expand

Symrise achieved very strong profitability

due to the progression of the COVID-19

in fast-growing, high-margin business

Industry leading sales growth

pandemic. The payment of the proposed

areas. We have also further diversified our

In the year under review, Symrise

dividend will also be postponed.

product portfolio in the attractive pet food

benefitted from good capacity utilisation

market and expanded our position in North

and strong demand in all segments and

Strong cash flow trend

America. In addition, we made investments

regions. The organic growth rate achieved

Symrise grew its normalised business free

to expand our capacities over the course of

a clear 5.7% increase. As a result, the

cash flow by 53% to €476 million in the

group exceeded the average market

year under review (2018: €312 million). This

growth rate in 2019, which was in the 3% to

represents 14.1% of sales, compared to 9.9%

4% range, according to estimates.

in the previous fiscal year.

The acquisition of the ADF/IDF Group,

The significant increase can be attributed

a leading US supplier of poultry and

above all to the strong gain in net income

egg-based protein specialties, which was

for the period and a below-average rise in

completed in November 2019, contributed

working capital.

approximately €32 million to group sales.

As at the date of reporting, net debt, including pension provisions and similar

Unaffected by fluctuating raw material costs

obligations, had increased to €2 221.5 million

The markets for raw materials remained

2019, the ratio of net debt – including

tense, especially in the first half of 2019.

pension provisions and similar obligations

Notwithstanding the above, Symrise

– to ebitda stood at 3.1, and showed little

continued to invest in global capacity

change compared to the level of the

expansion. Major investment projects

previous year (31 December 2018: 3.0). The

included the new manufacturing site in

medium-term target corridor for the ratio is

Nantong, China and the expansion of

2.0 to 2.5.

production capacity for menthol and

14

| APRIL 2020 | P C Review

(2018: €1 893.1 million). On 31 December

The equity ratio increased from 39.5% to

natural extracts in the US and for pet food in

41.4% at year-end, showing Symrise is in a

Colombia and France.

very good financial position.


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.